WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Oct 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-09-30

Reporting Person: LAI GOLDMAN MYLA (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-30	Phantom Stock Unit	$	A	134.9164	Acquired		Common Stock (134.9164)	Direct

Footnotes

F1: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.